SIO FENG: Open Payments
NPI 1245778513 · CAMPBELL, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,762 in 118 payments from 22 companies in 2025. Trend: 2023 $805 · 2024 $3,017 · 2025 $2,762
Food & beverage: $2,762
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $449 |
| Amgen Inc. | 12 | $331 |
| Lilly USA, LLC | 5 | $180 |
| Ascendis Pharma Endocrinology Inc | 4 | $171 |
| Aurinia Pharma U.S., Inc. | 7 | $164 |
| Abbott Laboratories | 11 | $159 |
| Madrigal Pharmaceuticals | 6 | $151 |
| SANOFI-AVENTIS U.S. LLC | 1 | $150 |
| Dexcom, Inc. | 7 | $148 |
| Bayer Healthcare Pharmaceuticals Inc. | 16 | $135 |
Products named: Ozempic, EVENITY, Yorvipath, LUPKYNIS, FREESTYLE LIBRE 3, Rybelsus, REZDIFFRA, TZIELD.
Industry payments across CA — which companies pay providers there.
